Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3032-3036

  Saukkonen, Kirsi ^a   Tomasetto, Catherine ^b   Narko, Kirsi ^a,c   Rio, Marie Christine ^b   Ristimäki, Ari ^a,d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; TREFOIL FACTOR 1; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ADENOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DYSPLASIA; ENZYME INHIBITION; GASTRITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PYLORUS; STOMACH TUMOR; STOMACH ULCER; TUMOR GROWTH;

ADENOMA; ANGIOGENESIS INHIBITORS; ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENZYME INDUCTION; GASTRIC MUCOSA; GASTRITIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; ISOENZYMES; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS; PEPTIDES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYLORUS; PYRAZOLES; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; STOMACH ULCER; SULFONAMIDES;

EID: 0038070069     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gupta, R. A., and DuBois, R. N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer, 1: 11-21, 2001.
2. 716 knockout mice by inhibition of cyclooxygeaase 2 (COX-2). Cell, 87: 803-809, 1996.
3. Steinbach, G., Lynch, P. M., Phillips, R. K., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L. K., and Levin, B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342: 1946-1952, 2000.
4. Sheehan, K. M., Sheahan, K., O'Donoghue, D. P., MacSweeney, F., Conroy, R. M., Fitzgerald, D. J., and Murray, F. E. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA, 282: 1254-1257, 1999.
5. Buskens, C. J., Van Rees, B. P., Sivula, A., Reitsma, J. B., Haglunth, C., Bosma, P. J., Offerhaus, G. J., Van Lanschot, J. J., and Ristimäki, A. Prognostic significance of elevated cyclooxygenase-2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology, 122: 1800-1807, 2002.
6. Ristimäki, A., Honkanen, N., Järkälä, H., Sipponen, P., and Härkönen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57: 1276-1280, 1997.
7. Saukkonen, K., Nieminen, O., van Rees, B., Vilkki, S., Härkönen, M., Juhola, M., Mecklin, J. P., Sipponen, P. and Ristimäki, A. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal type gastric adenocarcinoma. Clin. Cancer Res., 7: 1923-1931, 2001.
8. van Rees, B. P., Saukkonen, K., Ristimäki, A., Polkowski, W., Tytgat, G. N, Drillenburg, P., and Offerhaus, G. J. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol., 196: 171-179, 2002.
9. Ribieras, S., Tomasetto, C., and Rio, M. C. The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim. Biophys. Acta, 1378: 61-77, 1998.
10. Lefebvre, O., Chenard, M. P., Masson, R., Linares, J., Dierich, A., LeMeur, M., Wendling, C., Tomasetto, C., Chambon, P., and Rio, M. C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science, 274: 259-262, 1996.
11. Korpelainen, E. I., Karkkainen, M. J., Tenhunen, A., Lakso, M., Rauvala, H., Vierula, M., Parvinen, M., and Alitalo, K. Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. J. Cell Biol., 143: 1705-1712, 1998.
12. Heikinheimo, M., Ermolaeva, M., Bielinska, M., Rahman, N. A., Narita, N., Huhtaniemi, I. T., Tapanainen, J. S., and Wilson, D. B. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary. Endocrinology, 138: 3505-3514, 1997.
13. Hull, M. A., Booth, J. K., Tisbury, A., Scolt, N., Bonifer, C., Markham, A. F., and Colelta, P. L. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. Br. J. Cancer, 79: 1399-1405, 1999.
14. Shattuck-Brandt, R. L., Varilek, G. W., Radhika, A., Yang, F., Washington, M. K., and DuBois, R. N. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice. Gastroenterology, 118: 337-345, 2000.
15. Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., and DuBois, R. N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Investig., 105: 1589-1594, 2000.
16. Mizuno, H., Sakamoto, C., Matsuda, K., Wada, K., Uchida, T., Noguchi, H., Akmatsu, T., and Kasuga. M. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology. 112: 387-397, 1997.
17. Jones, M. K., Wang, H., Peskar, B. M., Levin, E., Itani, R. M., Sarfeh, I. J., and Tarnawski, A. S. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drug: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med., 5: 1418-1423, 1999.
18. Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., and Seibert, K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res., 60: 1306-1311, 2000.
19. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93: 705-716, 1998.
20. Newberry, R. D., Stenson, W. F., and Lorenz, R. G. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat. Med., 5: 900-906, 1999.
21. Reuter, B. K., Asfaha, S., Buret, A., Sharkey, K. A., and Wallace, J. L. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Investig., 98: 2076-2085, 1996.
22. Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., Lee, J. C., and Dubineth, S. M. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol., 164: 361-370, 2000.